Deutsche Bank Ag\ Argenx Se Transaction History
Deutsche Bank Ag\
- $262 Billion
- Q2 2025
A detailed history of Deutsche Bank Ag\ transactions in Argenx Se stock. As of the latest transaction made, Deutsche Bank Ag\ holds 19,930 shares of ARGX stock, worth $12.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,930
Previous 96,914
79.44%
Holding current value
$12.7 Million
Previous $57.4 Million
80.85%
% of portfolio
0.0%
Previous 0.02%
Shares
37 transactions
Others Institutions Holding ARGX
# of Institutions
493Shares Held
28.6MCall Options Held
376KPut Options Held
215K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$3.18 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.78 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$1.64 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.24 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$749 Million11.81% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.3B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...